STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $22.00 billion. The enterprise value is $24.16 billion.
| Market Cap | 22.00B |
| Enterprise Value | 24.16B |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | Feb 20, 2025 |
Share Statistics
STERIS has 98.25 million shares outstanding. The number of shares has decreased by -0.57% in one year.
| Current Share Class | 98.25M |
| Shares Outstanding | 98.25M |
| Shares Change (YoY) | -0.57% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 95.27% |
| Float | 97.88M |
Valuation Ratios
The trailing PE ratio is 35.99 and the forward PE ratio is 22.89.
| PE Ratio | 35.99 |
| Forward PE | 22.89 |
| PS Ratio | 4.09 |
| Forward PS | 3.83 |
| PB Ratio | 3.43 |
| P/TBV Ratio | 49.00 |
| P/FCF Ratio | 29.27 |
| P/OCF Ratio | 19.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.00, with an EV/FCF ratio of 32.15.
| EV / Earnings | 51.67 |
| EV / Sales | 4.48 |
| EV / EBITDA | 17.00 |
| EV / EBIT | 25.20 |
| EV / FCF | 32.15 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.13 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.55 |
| Debt / FCF | 3.09 |
| Interest Coverage | 9.11 |
Financial Efficiency
Return on equity (ROE) is 9.61% and return on invested capital (ROIC) is 6.41%.
| Return on Equity (ROE) | 9.61% |
| Return on Assets (ROA) | 5.59% |
| Return on Invested Capital (ROIC) | 6.41% |
| Return on Capital Employed (ROCE) | 10.52% |
| Revenue Per Employee | $296,956 |
| Profits Per Employee | $25,722 |
| Employee Count | 18,179 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 4.03 |
Taxes
In the past 12 months, STERIS has paid $171.48 million in taxes.
| Income Tax | 171.48M |
| Effective Tax Rate | 21.72% |
Stock Price Statistics
The stock price has increased by +11.48% in the last 52 weeks. The beta is 0.87, so STERIS's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +11.48% |
| 50-Day Moving Average | 222.78 |
| 200-Day Moving Average | 224.26 |
| Relative Strength Index (RSI) | 52.79 |
| Average Volume (20 Days) | 564,721 |
Short Selling Information
The latest short interest is 1.06 million, so 1.08% of the outstanding shares have been sold short.
| Short Interest | 1.06M |
| Short Previous Month | 1.04M |
| Short % of Shares Out | 1.08% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 1.63 |
Income Statement
In the last 12 months, STERIS had revenue of $5.40 billion and earned $467.59 million in profits. Earnings per share was $4.72.
| Revenue | 5.40B |
| Gross Profit | 2.37B |
| Operating Income | 958.73M |
| Pretax Income | 550.80M |
| Net Income | 467.59M |
| EBITDA | 1.42B |
| EBIT | 958.73M |
| Earnings Per Share (EPS) | $4.72 |
Balance Sheet
The company has $155.18 million in cash and $2.32 billion in debt, giving a net cash position of -$2.16 billion or -$22.03 per share.
| Cash & Cash Equivalents | 155.18M |
| Total Debt | 2.32B |
| Net Cash | -2.16B |
| Net Cash Per Share | -$22.03 |
| Equity (Book Value) | 6.43B |
| Book Value Per Share | 65.31 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was $1.14 billion and capital expenditures -$390.70 million, giving a free cash flow of $751.41 million.
| Operating Cash Flow | 1.14B |
| Capital Expenditures | -390.70M |
| Free Cash Flow | 751.41M |
| FCF Per Share | $7.65 |
Margins
Gross margin is 43.81%, with operating and profit margins of 17.76% and 8.66%.
| Gross Margin | 43.81% |
| Operating Margin | 17.76% |
| Pretax Margin | 14.62% |
| Profit Margin | 8.66% |
| EBITDA Margin | 26.33% |
| EBIT Margin | 17.76% |
| FCF Margin | 13.92% |
Dividends & Yields
This stock pays an annual dividend of $2.28, which amounts to a dividend yield of 1.02%.
| Dividend Per Share | $2.28 |
| Dividend Yield | 1.02% |
| Dividend Growth (YoY) | 9.85% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 48.32% |
| Buyback Yield | 0.57% |
| Shareholder Yield | 1.58% |
| Earnings Yield | 2.13% |
| FCF Yield | 3.42% |
Analyst Forecast
The average price target for STERIS is $260.00, which is 16.09% higher than the current price. The consensus rating is "Buy".
| Price Target | $260.00 |
| Price Target Difference | 16.09% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 6.47% |
| EPS Growth Forecast (5Y) | 24.29% |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 5.02 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.02 |
| Piotroski F-Score | 7 |